Hemenway Trust Hemenway Trust’s Beam Therapeutics BEAM Stock Holding History

Hemenway Trust Hemenway Trust’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,755	Closed	-$263K	–	127
2024 Q3	$263K	Hold	10,755	–	–	0.02%	117
2024 Q2	$252K	Hold	10,755	–	–	0.02%	118
2024 Q1	$355K	Hold	10,755	–	–	0.03%	104
2023 Q4	$293K	Buy	+10,755	New	+$267K	0.03%	109
2023 Q1	–	Sell	-5,680	Closed	-$222K	–	137
2022 Q4	$222K	Hold	5,680	–	–	0.02%	134
2022 Q3	$271K	Buy	+5,680	New	+$324K	0.03%	116
2021 Q4	–	Sell	-2,395	Closed	-$208K	–	142
2021 Q3	$208K	Buy	2,395 +425	+22%	+$42.7K	0.02%	137
2021 Q2	$254K	Buy	+1,970	New	+$157K	0.03%	125

Other funds holding BEAM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Hemenway Trust Hemenway Trust's BEAM Position: Q4 2024 in Review

Hemenway Trust Hemenway Trust sold out of Beam Therapeutics (BEAM) in Q4 2024, closing a stake of 10,755 shares — an estimated $263K sold.

Hemenway Trust Hemenway Trust first reported a position in BEAM in Q2 2021 and held it in 8 quarters. The position peaked at $355K in Q1 2024. 231 funds tracked by Wall St. Rank hold BEAM as of Q4 2024.

Hemenway Trust Hemenway Trust reported no remaining Beam Therapeutics position as of Q4 2024 after selling out during the quarter.
Hemenway Trust Hemenway Trust sold 10,755 Beam Therapeutics shares in Q4 2024, an estimated $263K.
Hemenway Trust Hemenway Trust first reported a position in Beam Therapeutics in Q2 2021 and held it in 8 quarters.
Hemenway Trust Hemenway Trust's Beam Therapeutics position peaked at $355K in Q1 2024.
231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2024.

Based on Hemenway Trust Hemenway Trust's 13F filing for Q4 2024, filed 13 Feb 2025.